Capabilities

Sale of the company to Bayer

Monsanto Company
2017-18

The firm successfully represented Monsanto in connection with its $66 billion acquisition by Bayer. The firm represented Monsanto in the US and EU and coordinated antitrust/competition approvals in almost 30 other jurisdictions worldwide in connection with the transaction.  The transaction was cleared after a 20 month investigation leading to Phase II remedies in the EU and a consent decree in the US that the DOJ characterized as “the largest negotiated merger divestiture ever required by the United States.”

Email Disclaimer